MTAR Technologies Limited (BOM:543270)

Market Cap	45.11B
Revenue (ttm)	6.76B
Net Income (ttm)	528.87M
Shares Out	n/a
EPS (ttm)	17.19
PE Ratio	85.29
Forward PE	48.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,033
Average Volume	3,970
Open	1,486.05
Previous Close	1,485.80
Day's Range	1,473.00 - 1,499.80
52-Week Range	1,152.00 - 1,953.20
Beta	n/a
RSI	31.40
Earnings Date	Aug 8, 2025

About Revance Therapeutics

MTAR Technologies Limited, a precision engineering solutions company, develops, manufactures, and sells high precision, heavy equipment, components, and machines in India and internationally. The company offers civilian nuclear power solution, which includes fuel machining head, drive mechanisms, bridge and column, hatch cover beam, coolant channel assemblies, grid plates, control plug, water lubricated bearings, and other products; clean energy solution; and structures, spiral casing, and rotar and stator assemblies for hydel, waste, energy, a...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1969
• Employees: 1,111
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543270

Financial Performance

In 2024, MTAR Technologies's revenue was 6.76 billion, an increase of 16.40% compared to the previous year's 5.81 billion. Earnings were 528.87 million, a decrease of -5.75%.